BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11319627)

  • 1. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
    Boozer CN; Nasser JA; Heymsfield SB; Wang V; Chen G; Solomon JL
    Int J Obes Relat Metab Disord; 2001 Mar; 25(3):316-24. PubMed ID: 11319627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN; Daly PA; Homel P; Solomon JL; Blanchard D; Nasser JA; Strauss R; Meredith T
    Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected caffeine and ephedrine toxicosis resulting from ingestion of an herbal supplement containing guarana and ma huang in dogs: 47 cases (1997-1999).
    Ooms TG; Khan SA; Means C
    J Am Vet Med Assoc; 2001 Jan; 218(2):225-9. PubMed ID: 11195828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
    Coffey CS; Steiner D; Baker BA; Allison DB
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1411-9. PubMed ID: 15356670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
    Hackman RM; Havel PJ; Schwartz HJ; Rutledge JC; Watnik MR; Noceti EM; Stohs SJ; Stern JS; Keen CL
    Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients.
    Andersen T; Fogh J
    J Hum Nutr Diet; 2001 Jun; 14(3):243-50. PubMed ID: 11424516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
    Belza A; Frandsen E; Kondrup J
    Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
    Kalman D; Incledon T; Gaunaurd I; Schwartz H; Krieger D
    Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1363-6. PubMed ID: 12355332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a single dose of multivitamin and mineral combinations with and without guaraná on functional brain activity during a continuous performance task.
    White DJ; Camfield DA; Maggini S; Pipingas A; Silberstein R; Stough C; Scholey A
    Nutr Neurosci; 2017 Jan; 20(1):8-22. PubMed ID: 25259737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: a six-week exploratory study.
    Woodgate DE; Conquer JA
    Curr Ther Res Clin Exp; 2003 Apr; 64(4):248-62. PubMed ID: 24944372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
    Greenway FL; De Jonge L; Blanchard D; Frisard M; Smith SR
    Obes Res; 2004 Jul; 12(7):1152-7. PubMed ID: 15292480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A; Breum L; Toubro S; Hein P; Quaade F
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
    Vukovich MD; Schoorman R; Heilman C; Jacob P; Benowitz NL
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):47-53. PubMed ID: 15730434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans.
    Haskell CF; Kennedy DO; Wesnes KA; Milne AL; Scholey AB
    J Psychopharmacol; 2007 Jan; 21(1):65-70. PubMed ID: 16533867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans.
    Greenway FL; Raum WJ; DeLany JP
    J Altern Complement Med; 2000 Dec; 6(6):553-5. PubMed ID: 11152061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2002 Jun; 71(6):421-32. PubMed ID: 12087345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of HT048 and HT077 for body fat and weight loss in overweight adults: A study protocol for a double-blind, randomized, placebo-controlled trial.
    Song J; Shin SM; Kim H
    Medicine (Baltimore); 2019 Nov; 98(45):e17922. PubMed ID: 31702673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
    Molnár D; Török K; Erhardt E; Jeges S
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2005 Jun; 77(6):560-71. PubMed ID: 15961987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.